Examining the Effects of CXB722 in Neuroendocrine Stress Response in Healthy Males
Clinical trial NCT00814931 · COMPLETED
Trial details
- NCT number
- NCT00814931
- Sponsor
- CeNeRx BioPharma Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2008-12-01
- Primary completion
- 2008-12-01
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.